FDA's Hamburg Interview on GlaxoSmithKline Plc's Avandia

Loading player, please wait...
  • Info

  • Comments

Sept. 23 (Bloomberg) -- Margaret Hamburg, commissioner of the Food and Drug Administration, talks with Bloomberg's Melissa Long and Michael Waldholz about the FDA's decision to restrict the use of GlaxoSmithKline Plc's Avandia. Avandia, once the world's best-selling diabetes drug, will be withdrawn in Europe and restricted in the U.S. after a three-year review of the medicine's heart risks. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change